Post-approval studies (Phase 4)Looking for participantsNCT05854615
What this trial is testing
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Who this might be right for
Critical Limb IschemiaBuerger's Disease
Cell Biopeutics Resources Sdn Bhd 3